Jefferies Lifts Target on Biogen (BIIB) to $176, Hemophilia Data Adds To Valuation
Go back to Jefferies Lifts Target on Biogen (BIIB) to $176, Hemophilia Data Adds To Valuation| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.73 -0.1 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.83 | 52 Week High | $333.65 | |||
| Open | $208.36 | 52 Week Low | $223.02 | |||
| Day High | $210.32 | P/E | 26.85 | |||
| Day Low | $207.62 | EPS | $7.81 | |||
| Volume | 93,503 | |||||
